4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-21-004573
Options or other derivatives
- President and CEO acquired 199,700 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Session R.A. II President and CEO | 2021-01-19 | Grant or award · Stock Option (Right to Buy) | +199,700 | 199,700 | D | ||
Loading xslF345X03/doc4.xml…